Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 7

    1.

    Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.

    Soond SM, Chantry A.

    Oncogene. 2011 May 26;30(21):2451-62. Epub 2011 Jan 24.

    PMID:
    21258410
    [PubMed - indexed for MEDLINE]
    2.

    Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.

    Ito I, Hanyu A, Wayama M, Goto N, Katsuno Y, Kawasaki S, Nakajima Y, Kajiro M, Komatsu Y, Fujimura A, Hirota R, Murayama A, Kimura K, Imamura T, Yanagisawa J.

    J Biol Chem. 2010 May 7;285(19):14747-55. Epub 2010 Mar 5.

    PMID:
    20207742
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.

    Runyan CE, Hayashida T, Hubchak S, Curley JF, Schnaper HW.

    J Biol Chem. 2009 Sep 11;284(37):25181-9. Epub 2009 Jul 20.

    PMID:
    19620243
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).

    Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Miyazawa K.

    Oncogene. 2004 Sep 9;23(41):6914-23.

    PMID:
    15221015
    [PubMed - indexed for MEDLINE]
    7.

    Ubiquitin-dependent degradation of TGF-beta-activated smad2.

    Lo RS, Massagué J.

    Nat Cell Biol. 1999 Dec;1(8):472-8.

    PMID:
    10587642
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk